HBIO (STOCKS)
Harvard Bioscience Inc
$4.655000
+0.345000 (+8.00%)
Prev close: $4.310000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John D. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.82M
- Employees
- 355
- P/E (TTM)
- -0.36
- P/B (TTM)
- 1.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.00 | $0.36 | -0.3570 | -100.00% |
|
Sep 2025 (Q3)
|
$0.00 | $0.05 | -0.0510 | -100.00% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.10 | +0.0020 | +1.96% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.41 | +0.3080 | +75.49% |
Financial Statements
| Revenues | $86.55M |
| Benefits Costs and Expenses | $143.94M |
| Cost Of Revenue | $36.64M |
| Costs And Expenses | $143.94M |
| Gross Profit | $49.91M |
| Nonoperating Income/Loss | -$8.81M |
| Operating Expenses | $98.49M |
| Research and Development | $8.83M |
| Other Operating Expenses | $89.67M |
| Operating Income/Loss | -$48.58M |
| Income/Loss From Continuing Operations After Tax | -$56.70M |
| Income/Loss From Continuing Operations Before Tax | -$57.39M |
| Income Tax Expense/Benefit | -$686.00K |
| Income Tax Expense/Benefit, Current | -$133.00K |
| Income Tax Expense/Benefit, Deferred | -$553.00K |
| Net Income/Loss | -$56.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$56.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$56.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.28 |
| Diluted Earnings Per Share | -$1.28 |
| Basic Average Shares | 44,391,000 |
| Diluted Average Shares | 44,391,000 |
| Assets | $80.07M |
| Current Assets | $48.23M |
| Inventory | $20.81M |
| Other Current Assets | $27.42M |
| Noncurrent Assets | $31.85M |
| Fixed Assets | $4.79M |
| Intangible Assets | $7.64M |
| Other Non-current Assets | $19.42M |
| Liabilities | $66.34M |
| Current Liabilities | $21.96M |
| Accounts Payable | $3.65M |
| Wages | $1.82M |
| Other Current Liabilities | $16.49M |
| Noncurrent Liabilities | $44.38M |
| Long-term Debt | $35.87M |
| Other Non-current Liabilities | $8.51M |
| Equity | $13.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.73M |
| Liabilities And Equity | $80.07M |
| Net Cash Flow From Operating Activities | $6.73M |
| Net Cash Flow From Operating Activities, Continuing | $6.73M |
| Net Cash Flow From Investing Activities | -$1.86M |
| Net Cash Flow From Investing Activities, Continuing | -$1.86M |
| Net Cash Flow From Financing Activities | -$1.29M |
| Net Cash Flow From Financing Activities, Continuing | -$1.29M |
| Net Cash Flow | $3.58M |
| Net Cash Flow, Continuing | $3.58M |
| Comprehensive Income/Loss | -$52.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.70M |
| Other Comprehensive Income/Loss | $4.00M |